Advertisement

Psychopharmacology

, Volume 236, Issue 1, pp 273–279 | Cite as

Prazosin during fear conditioning facilitates subsequent extinction in male C57Bl/6N mice

  • Elizabeth K. Lucas
  • Wan-Chen Wu
  • Ciorana Roman-Ortiz
  • Roger L. ClemEmail author
Original Investigation

Abstract

Rationale

Recovery from a traumatic experience requires extinction of cue-based fear responses, a process that is impaired in post-traumatic stress disorder. While studies suggest a link between fear behavioral flexibility and noradrenaline signaling, the role of specific receptors and brain regions in these effects is unclear.

Objectives

Here, we examine the role of prazosin, an α1-adrenergic receptor (α1-AR) antagonist, in auditory fear conditioning and extinction.

Methods

C57Bl/6N mice were subjected to auditory fear conditioning and extinction in combination with systemic (0.1–2 mg/kg) or local microinjections (3 or 6 mM) of the α1-AR antagonist prazosin into the prelimbic division of medial prefrontal cortex or basolateral amygdala. Conditioned fear and anxiety-like behaviors were compared with vehicle-injected control animals.

Results

Mice that received systemic prazosin prior to fear conditioning exhibited similar initial levels of cue-elicited freezing compared to vehicle controls on the following day. However, at all doses tested, fear that was acquired during prazosin treatment was more readily extinguished, whereas anxiety-like behavior on the day of extinction was unaffected. A similar pattern of results was observed when prazosin was microinjected into the basolateral amygdala but not the prelimbic cortex. In contrast to pre-conditioning injections, prazosin administration prior to extinction had no effect on freezing.

Conclusions

Our results indicate that α1-AR activity during aversive conditioning is dispensable for memory acquisition but renders conditioned fear more impervious to extinction. This suggests that behavioral flexibility is constrained by noradrenaline at the time of initial learning via activation of a specific AR isoform.

Keywords

ADRA1A Terazosin Exposure therapy 

Notes

Acknowledgments

We would like to thank Stephen Salton, Matthew Shapiro, Paul Kenny, Anne Shaefer, Schahram Akbarian, Zhenyu Yue, and Glenn Cruse for the use of equipment, and Wei-Jye Lin, Kirstie Cummings, Molly Heyer, and Philip Avigan for technical advice and assistance.

Funding information

This work was funded by NIH grant MH105414 (R.L.C.) and seed funds from NC State University (E.K.L).

Supplementary material

213_2018_5001_Fig4_ESM.png (229 kb)
Figure S1

Fear acquired during α1-AR blockade is more readily extinguished in 8–12 week old male mice. A. Experimental timeline. B. Systemic injection of prazosin (1 mg/kg) prior to fear conditioning significantly reduced freezing behavior during extinction day 2 while having no effect on fear memory acquisition or retrieval (Extinction 1, CS 1–4). Two-way repeated-measures ANOVA, p < 0.05 for main effect of treatment. n/group indicated in parentheses in legend. CS, conditioned stimulus. (PNG 228 kb)

213_2018_5001_MOESM1_ESM.tif (2.8 mb)
High Resolution image (TIF 2864 kb)
213_2018_5001_Fig5_ESM.png (144 kb)
Figure S2

No effect of prazosin on cue-evoked freezing after low threshold training. A. Experimental timeline. B. Systemic injection of prazosin (2 mg/kg) prior to low-intensity fear conditioning (3 tone-shock pairings) did not affect fear memory retrieval. n/group indicated in parentheses in legend. (PNG 144 kb)

213_2018_5001_MOESM2_ESM.tif (2 mb)
High Resolution image (TIF 2012 kb)
213_2018_5001_Fig6_ESM.png (1.1 mb)
Figure S3

Map of cannula placement in Fig. 3. A. Prelimbic cortex cannula placements. B. Basolateral amygdala cannula placements. Taxonomy according to The Mouse Brain in Stereotaxic Coordinates, 3rd Edition, by Franklin & Paxinos (2007). (PNG 1144 kb)

213_2018_5001_MOESM3_ESM.tif (43.8 mb)
High Resolution image (TIF 44853 kb)

References

  1. Braga MF, Aroniadou-Anderjaska V, Manion ST, Hough CJ, Li H (2004) Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala. Neuropsychopharmacology 29:45–58CrossRefGoogle Scholar
  2. Bush DE, Caparosa EM, Gekker A, Ledoux J (2010) Beta-adrenergic receptors in the lateral nucleus of the amygdala contribute to the acquisition but not the consolidation of auditory fear conditioning. Front Behav Neurosci 4:154CrossRefGoogle Scholar
  3. Davis P, Zaki Y, Maguire J, Reijmers LG (2017) Cellular and oscillatory substrates of fear extinction learning. Nat Neurosci 20:1624–1633CrossRefGoogle Scholar
  4. Do Monte FH, Souza RR, Wong TT, de Padua Carobrez A (2013) Systemic or intra-prelimbic cortex infusion of prazosin impaired fear memory reconsolidation. Behav Brain Res 244:137–141CrossRefGoogle Scholar
  5. Fitzgerald PJ, Giustino TF, Seemann JR, Maren S (2015) Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress. Proc Natl Acad Sci U S A 112:E3729–E3737CrossRefGoogle Scholar
  6. Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates third edition. Academic Press, New YorkGoogle Scholar
  7. Gazarini L, Stern CA, Piornedo RR, Takahashi RN, Bertoglio LJ (2015) PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation Int J Neuropsychopharmacol 18:pyu026Google Scholar
  8. George KC, Kebejian L, Ruth LJ, Miller CW, Himelhoch S (2016) Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. J Trauma Dissociation 17:494–510CrossRefGoogle Scholar
  9. Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE Jr, Kasckow JW (2001) CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 158:1227–1230CrossRefGoogle Scholar
  10. Giustino TF, Seemann JR, Acca GM, Goode TD, Fitzgerald PJ, Maren S (2017) Beta-adrenoceptor blockade in the basolateral amygdala, but not the medial prefrontal cortex, rescues the immediate extinction deficit. Neuropsychopharmacology 42:2537–2544CrossRefGoogle Scholar
  11. Grewe BF, Grundemann J, Kitch LJ, Lecoq JA, Parker JG, Marshall JD, Larkin MC, Jercog PE, Grenier F, Li JZ, Luthi A, Schnitzer MJ (2017) Neural ensemble dynamics underlying a long-term associative memory. Nature 543:670–675CrossRefGoogle Scholar
  12. Grillon C, Cordova J, Morgan CA, Charney DS, Davis M (2004) Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans. Psychopharmacology 175:342–352CrossRefGoogle Scholar
  13. Han SK, Chong W, Li LH, Lee IS, Murase K, Ryu PD (2002) Noradrenaline excites and inhibits GABAergic transmission in parvocellular neurons of rat hypothalamic paraventricular nucleus. J Neurophysiol 87:2287–2296CrossRefGoogle Scholar
  14. Herry C, Ciocchi S, Senn V, Demmou L, Muller C, Luthi A (2008) Switching on and off fear by distinct neuronal circuits. Nature 454:600–606CrossRefGoogle Scholar
  15. Hillman KL, Lei S, Doze VA, Porter JE (2009) Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. Epilepsy Res 84:97–109CrossRefGoogle Scholar
  16. Homan P, Lin Q, Murrough JW, Soleimani L, Bach DR, Clem RL, Schiller D (2017) Prazosin during threat discrimination boosts memory of the safe stimulus. Learn Mem 24:597–601CrossRefGoogle Scholar
  17. Jovanovic T, Norrholm SD (2011) Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder. Front Behav Neurosci 5:44PubMedPubMedCentralGoogle Scholar
  18. Kaneko K, Tamamaki N, Owada H, Kakizaki T, Kume N, Totsuka M, Yamamoto T, Yawo H, Yagi T, Obata K, Yanagawa Y (2008) Noradrenergic excitation of a subpopulation of GABAergic cells in the basolateral amygdala via both activation of nonselective cationic conductance and suppression of resting K+ conductance: a study using glutamate decarboxylase 67-green fluorescent protein knock-in mice. Neuroscience 157:781–797CrossRefGoogle Scholar
  19. Lazzaro SC, Hou M, Cunha C, LeDoux JE, Cain CK (2010) Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear conditioning and long-term potentiation. Learn Mem 17:489–493CrossRefGoogle Scholar
  20. Liberzon I, Abelson JL, Flagel SB, Raz J, Young EA (1999) Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21:40–50CrossRefGoogle Scholar
  21. Lin CC, Tung CS, Lin PH, Huang CL, Liu YP (2016) Traumatic stress causes distinctive effects on fear circuit catecholamines and the fear extinction profile in a rodent model of posttraumatic stress disorder. Eur Neuropsychopharmacol 26:1484–1495CrossRefGoogle Scholar
  22. Lucas EK, Jegarl A, Clem RL (2014) Mice lacking TrkB in parvalbumin-positive cells exhibit sexually dimorphic behavioral phenotypes. Behav Brain Res 274:219-225Google Scholar
  23. Lucas EK, Jegarl A, Morishita H, Clem RL (2016) Multimodal and site-specific plasticity of amygdala parvalbumin interneurons after fear learning. Neuron 91:629–643CrossRefGoogle Scholar
  24. Luo F, Tang H, Cheng ZY (2015) Stimulation of alpha1-adrenoceptors facilitates GABAergic transmission onto pyramidal neurons in the medial prefrontal cortex. Neuroscience 300:63–74CrossRefGoogle Scholar
  25. Maren S, Holmes A (2016) Stress and fear extinction. Neuropsychopharmacology 41:58–79CrossRefGoogle Scholar
  26. Milad MR, Quirk GJ (2012) Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 63:129–151CrossRefGoogle Scholar
  27. Pervanidou P, Chrousos GP (2012) Posttraumatic stress disorder in children and adolescents: neuroendocrine perspectives. Sci Signal 5:pt6CrossRefGoogle Scholar
  28. Pitman RK (1989) Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry 26:221–223CrossRefGoogle Scholar
  29. Quirarte GL, Galvez R, Roozendaal B, McGaugh JL (1998) Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res 808:134–140CrossRefGoogle Scholar
  30. Rodrigues SM, LeDoux JE, Sapolsky RM (2009) The influence of stress hormones on fear circuitry. Annu Rev Neurosci 32:289–313CrossRefGoogle Scholar
  31. Singh B, Hughes AJ, Mehta G, Erwin PJ, Parsaik AK (2016) Efficacy of prazosin in posttraumatic stress disorder: a systematic review and meta-analysis. Prim Care Companion CNS Disord 18:PCC.16r01943.Google Scholar
  32. Skelly MJ, Ariwodola OJ, Weiner JL (2017) Fear conditioning selectively disrupts noradrenergic facilitation of GABAergic inhibition in the basolateral amygdala. Neuropharmacology 113:231–240CrossRefGoogle Scholar
  33. Soeter M, Kindt M (2011) Noradrenergic enhancement of associative fear memory in humans. Neurobiol Learn Mem 96:263–271CrossRefGoogle Scholar
  34. Soeter M, Kindt M (2012) Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation. Neuropsychopharmacology 37:1204–1215CrossRefGoogle Scholar
  35. Taylor JA, Twomey TM, von Wittenau MS (1977) The metabolic fate of prazosin. Xenobiotica 7:357–364CrossRefGoogle Scholar
  36. Trouche S, Sasaki JM, Tu T, Reijmers LG (2013) Fear extinction causes target-specific remodeling of perisomatic inhibitory synapses. Neuron 80:1054–1065CrossRefGoogle Scholar
  37. Yehuda R, McFarlane AC, Shalev AY (1998) Predicting the development of posttraumatic stress disorder from the acute response to a traumatic event. Biol Psychiatry 44:1305–1313CrossRefGoogle Scholar
  38. Zuj DV, Palmer MA, Lommen MJ, Felmingham KL (2016) The centrality of fear extinction in linking risk factors to PTSD: a narrative review. Neurosci Biobehav Rev 69:15–35CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Fishberg Department of Neuroscience and the Friedman Brain InstituteIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Department of Molecular Biomedical SciencesNorth Carolina State UniversityRaleighUSA
  3. 3.Department of PsychiatryIcahn School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations